Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer

Cited by (176)

Items 101–176 of 176

1. Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: the necessity of repeated molecular analysis
   J.L. González-Larriba, Martín Lázaro-Quintela, Manuel Cobo, Manuel Dómine, Margarita Majem, Rosario García‐Campelo · 2017 · Translational Lung Cancer Research
2. Molecular Determinants of Radiation Response in Non–Small Cell Lung Cancer
   Sue Sun Yom, Maximilian Diehn, David Raben · 2014 · Seminars in Radiation Oncology
3. FGFR1Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status
   Sara E. Monaco, Erika F. Rodriguez, Alyssa L. Mahaffey, Sanja Đačić · 2015 · American Journal of Clinical Pathology
4. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas
   Nicole Ezer, Hangjun Wang, Andrea Corredor, Pierre Fiset, Ayesha Baig, Léon C.L.T. van Kempen, George Chong, Marianne Samir Makboul Issac, Richard S. Fraser, Alan Spatz et al. · 2021 · Cancer Treatment and Research Communications
5. Epidermal Growth Factor Receptor Mutated Advanced Non–Small Cell Lung Cancer
   Suchita Pakkala, Suresh S. Ramalingam · 2016 · Hematology/Oncology Clinics of North America
6. RETRACTED: Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM
   Xiaohui Wang, Yuan Gong, Jianfei Yao, Yan Chen, Yuemin Li, Zhen Zeng, Yinying Lu, Lele Song · 2021 · Frontiers in Oncology · Retracted
7. Different efficacy in the non-small cell lung cancer patient with bilateral synchronous lesions treated with neoadjuvant gefitinib therapy: a case report
   Wenxing Du, Yandong Zhao, Yunpeng Xuan, Yi Qin, Rongjian Xu, Balázs Halmos, Thomas Fabian, Wenjie Jiao · 2020 · Journal of Thoracic Disease
8. Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma
   Runzhe Chen, Jun Li, Junya Fujimoto, Lingzhi Hong, Xin Hu, Kelly Quek, Ming Tang, Akash Mitra, Carmen Behrens, Chi-Wan B. Chow et al. · 2022 · Journal of Experimental & Clinical Cancer Research
9. Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort
   Donglin Zhu, Dan Cao, Minghong Shen, Jinghuan Lv · 2021 · BMC Cancer
10. Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules
    Erika F. Rodriguez, Li‐Hui Tseng, Federico De Marchi, Jialing Haung, Deborah Belchis, Rena R. Xian, Christopher D. Gocke, James R. Eshleman, Peter Bela Illei, Ming‐Tseh Lin · 2020 · Molecular Diagnosis & Therapy
11. Rediscovering Secondary Tumors of the Prostate in the Molecular Era
    Nicola Fusco, Amedeo Sciarra, Elena Guerini‐Rocco, Caterina Marchiò, Francesca Vignani, Piergiuseppe Colombo, Stefano Ferrero · 2016 · Advances in Anatomic Pathology
12. Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
    Kajsa Ericson Lindquist, Anna Johansson, Per Levéen, Göran Elmberger, Goran B Jönsson, Johan Staaf, Hans Brunnström · 2017 · Diagnostic Pathology
13. Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases
    George David Wilson, Matthew D. Johnson, Samreen I. Ahmed, Paola Yumpo Cardenas, Inga Siiner Grills, Bryan J. Thibodeau · 2018 · Oncotarget
14. Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens
    Li‐Hui Tseng, Federico De Marchi, Aparna Pallavajjalla, Erika F. Rodriguez, Rena R. Xian, Deborah Belchis, Christopher D. Gocke, James R. Eshleman, Peter Bela Illei, Ming‐Tseh Lin · 2019 · American Journal of Clinical Pathology
15. Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer
    Sawsan Rashdan, Puneeth Iyengar, John Dorrance Minna, David E. Gerber · 2021 · Translational Lung Cancer Research
16. A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol
    Milagros González‐Rivera, Antoni C. Picornell, Enrique L. Álvarez, Miguel Martín · 2016 · JMIR Research Protocols
17. Discordances entre tumeur primitive et métastases : quel impact sur le développement de la médecine personnalisée ?
    Stéphane Vignot, Jean‐Charles Soria · 2013 · Bulletin du Cancer
18. Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma
    Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, Shingo Kimura, Fumiko Irisuna, Kyoko Ikeda, Kei Kushitani, Naoto Kishi, Yasuhiro Tsutani, Yukio Takeshima et al. · 2019 · Journal of Cancer Research and Clinical Oncology
19. Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins
    Michael Allgäeuer, Klaus Kluck, Petros Christopoulos, Markus Ball, Anna‐Lena Volckmar, Teodora R Radonic, Lukas Bubendorf, Paul M Hofman, Claus Peter Heußel, Hauke Winter et al. · 2025 · Journal of Thoracic Oncology
20. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma
    Tōru Yamada, Yoshitsugu Nakanishi, Hideyuki Hayashi, Shigeki Tanishima, Ryo Mori, Kyōkō Fujii, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji et al. · 2021 · HPB
21. Lung Adenocarcinoma Metastasis to the Prostate: A Case Report
    Natasha Gilmour, Wambaka Ange Mampuya, Raphael Jumeau, Nicolas Dattner, Mahmut Özşahin · 2019 · Practical Radiation Oncology
22. Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma Sharing the PCM1-JAK2 Fusion and a Common T-Cell Clone
    Gregory Riedlinger, Aleksander Lech Chojecki, Hana Aviv, David J. Weissmann, Sonali S. Joshi, Susan Murphy, Kim Marie Hirshfield, Shridar Ganesan · 2019 · JCO Precision Oncology
23. Molecular evolution of central nervous system metastasis and therapeutic implications
    David Gritsch, Priscilla Kaliopi Brastianos · 2024 · Trends in Molecular Medicine
24. Tackling the cancer signal transduction “Labyrinth”: A combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defect
    Michalis V. Karamouzis, Athanasios G. Papavassiliou · 2013 · Cancer
25. [Surgical Treatment and Prognosis for Patients with Synchronous Multiple Primary Lung Adenocarcinomas].
    Yue Peng, Hui Wang, Hounai Xie, Wangang Ren, Zhen Feng, Meng Li, Zhongmin Peng · 2017 · Europe PMC (PubMed Central)
26. Les méthodes de séquençage de « nouvelle génération » (NGS) et le cancer broncho-pulmonaire: principales technologies, applications et limites actuelles en pathologie
    Marius Ilié, Élodie Long-Mira, Véronique Hofman, Virginie Lespinet‐Fabre, Olivier Bordone, Kevin Washetine, Virginie Tanga, Paul M Hofman · 2014 · Revue Francophone des Laboratoires
27. Core needle biopsy for screening detected lung cancer—does it capture all in light of tumor heterogeneity?—a narrative review
    Carina Binder, Felicitas Oberndorfer, Leonhard Müllauer · 2021 · Shanghai Chest
28. Clinical and genetic characteristics of early‐stage multiple primary and independent primary lung adenocarcinoma patients
    Peng Li, Ronghua Yang, Dong Wang, Lingjie Wang, Sai Wang, Chuan Liu, Jinlong Li, Ling Li, Chuang Liu, Yan Tong et al. · 2022 · Asia-Pacific Journal of Clinical Oncology
29. Genetic Intratumor Heterogeneity
    Donát Alpár, Louise J. Barber, Marco Gerlinger · 2015 · Elsevier eBooks
30. A comparison on expression of selected biomarkers between primary lung cancers and matched metastases
    Dongwei Gao, Tiehong Zhang, Sha Li, Qi Liu, Jiajun Du · 2013 · Medical Oncology
31. Cancer Biology and the Principles of Targeted Cancer Drug Discovery
    Petra Hillmann, Debora Schmitz, Jürgen Mestan, Saana D'Allonzo, Doriano Fabbro · 2016 · Elsevier eBooks
32. Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors
    Stephanie A. Harmon, Michael J. Tuite, Robert Jeraj · 2016 · Physics in Medicine and Biology
33. Classifying multiple lung cancers using morphological features: a meta-analysis
    Mona Mlika, Mohamed Majdi Zorgati, Faouzi El Mezni · 2020 · Journal of Immunoassay and Immunochemistry
34. An introduction to stratified medicine
    Alastair Greystoke, Anshuman Chaturvedi · 2015 · Drug Discovery Today
35. Lung Carcinoma Staging Update
    Sanja Đačić · 2016 · Archives of Pathology & Laboratory Medicine
36. Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology‐proven malignant pleural effusions
    Cristiana M. Pineda, Adnan Majid, Daniel Botelho Costa, Paul A. VanderLaan · 2024 · Cancer Cytopathology
37. A pairwise radiomics algorithm–lesion pair relation estimation model for distinguishing multiple primary lung cancer from intrapulmonary metastasis
    Ting-Fei Chen, Lei Yang, Hai-Bin Chen, Zhiguo Zhou, Zhen-Tian Wu, Honghe Luo, Qiong Li, Ying Yan Zhu · 2023 · Precision Clinical Medicine
38. Design and statistical principles of the SHIVA trial.
    Xavier Paolettí, Bernard Jean Roger Asselain, Maud T Kamal, Nicolas Servant, Philippe Huppé, Ivan Bièche, Christophe Le Tourneau · 2015 · PubMed
39. [Diagnosis and Treatment of Multiple Primary Lung Cancer].
    Jingjing Hou, Huijuan Wang, Guowei Zhang, Zhiyong Ma · 2015 · Europe PMC (PubMed Central)
40. Next-Generation Sequencing for Drug Designing and Development: An Omics Approach for Cancer Treatment
    Gautam Kumar, Kamal Kishore Chaudhary, Krishna Misra, Anushree Tripathi · 2017 · International Journal of Pharmacology
41. Molecular Therapeutics of Non-Small Cell Lung Cancer (NSCLC) and Challenges in Repeat Tissue Biopsy
    Devanna Vasista Ganesha, Radheshyam Naik, Suhail Sayeed Mufti, Hrishi Varayathu · 2021 · Advances in Lung Cancer
42. Next-Generation Sequencing of Cancer Genomes: Lessons Learned
    Amber Elyse Corrigan, Robert Taylor, Kathrine S Rallis · 2021 · Future Oncology
43. Novel causes and assessments of intrapulmonary metastasis
    Ming Soon Cheng, Shujun Shao, Wei Xu, Dazhi Liu · 2025 · Biochemistry and Biophysics Reports
44. Cancer Clonal Evolution and Intra-tumor Heterogeneity
    Daniele Fanale, Juan Iovanna, Antonio Giordano, Christian D. Rolfo, Antonio Dello Russo · 2017 · Current clinical pathology
45. Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer
    Keisuke Asakura, Yukihiro Yoshida, Hiroyuki Sakurai, Kazuo Nakagawa, Noriko Motoi, Shun-ichi I. WATANABE · 2019 · World Journal of Surgery
46. [Progress in Basic Research and Clinical Treatment of Multiple Pulmonary Nodules].
    Xuejie Wu, Donglai Chen, Rongying Zhu, Yifei Wang, Chang Chen, Yongbing Chen, Wentao Yang · 2019 · PubMed Central
47. SNAILs promote G1 phase in selected cancer cells
    Yalan Wu, Jianxin Xue, Lin Zhou, Lei Deng, Yanna Shang, Fang Liu, Xianming Mo, You Lü · 2015 · International Journal of Oncology
48. Development in the Diagnostic Lung Cancer Pathway: Implication for Treatment
    Cristina Migali, Anna Maria Bielinska, Jaishree Bhosle, Mary O’Brien · 2014 · Lung Cancer Management
49. Carcinomes bronchiques non à petites cellules (CBNPC) métastatiques, mutés ou réarrangés : comment déterminer la cible ?
    Michèle Beau‐Faller, Stéphane Renaud, Noëlle Weingertner, Véronique Lindner, C. Emprou, Pauline Le Van Quyen, M. Legrain, Anne‐Claire Voegeli, Marie‐Pierre Chenard, Erwan Pencreach et al. · 2015 · Revue des Maladies Respiratoires Actualités
50. The current and future roles of genomics
    Kwun Meng Fong, Marissa G. Daniels, Felicia Goh, Ian A. Yang, Rayleen Bowman · 2015 · European Respiratory Society eBooks
51. The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
    Natalie I. Vokes, Jianjun J. Zhang · 2021 · Lung Cancer Targets and Therapy
52. Clinical and Pathological Research Status of Multiple Pulmonary Nodules
    Yun Wang, Shiqi Song, Jian Huang · 2023 · Journal of Cancer Therapy
53. Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?
    Hiroaki Aizawa, Takahiro Karasaki, Kazuhiro Nagayama, Aya Shinozaki‐Ushiku, Hiroyuki Aburatani, Hiroyuki Mano, Jun Nakajima · 2020 · Internal Medicine
54. Utility of Next-Generation Sequencing in Cancer Drug Development and Clinical Trials
    François Thomas, Ahmad Hussein Awada · 2015 · Springer eBooks
55. Tumor subclone structure reconstruction with genomic variation data
    Yi Qiao · 2014
56. Deciphering the role of SerpinB2 in cancer invasion and metastasis
    Nathanial Lachlan Ewart Harris · 2017 · Research Online (University of Wollongong)
57. A case of second primary lung cancer diagnosed by surgical resection at salvage setting
    Shozo Sakata, Tetsuya Mizuno, Hitoshi Dejima, Takaaki Arimura, Hiroaki Kuroda, Noriaki Sakakura, Yasushi Yatabe, Yukinori Sakao · 2018 · International Cancer Conference Journal
58. What we have known, what we do not know?—clonality of multifocal pulmonary ground-glass opacities
    Jun Wang · 2018 · Journal of Thoracic Disease
59. Quel avenir pour les biopsies liquides en oncologie thoracique ?
    Nicolas Marie Guibert, Jessica Garcia, S. Couraud · 2019 · Revue des Maladies Respiratoires Actualités
60. Unusual metachronous lung adenocarcinomas harboring EGFR L858R / T790M mutations: A case report
    Guotian Pei, Shanbo Cao, Yuqing Huang · 2020 · Thoracic Cancer
61. A comparison on expression of selected biomarkers between primary lung cancers and matched metastases
    Dongwei GaoTiehong, ZhangSha Li · 2013
62. Quel avenir pour les biopsies liquides en oncologie thoracique ?
    Nicolas Marie Guibert, Jessica Garcia, S. Couraud · 2020 · Revue des Maladies Respiratoires Actualités
63. Immunogenomic Intertumor Heterogeneity Across Primary and Metastatic Sites in a Patient With Lung Adenocarcinoma
    Runzhe Chen, Jun Li, Junya Fujimoto, Xin Hu, Kelly Quek, Ming Tang, Akash Mitra, Carmen Behrens, Chi-Wan B. Chow, Peixin Jiang et al. · 2021 · Research Square
64. Tumor Biology and Natural History
    Daniele Fanale, Juan Iovanna, Antonio Giordano, Antonio Giampiero Russo, Viviana Bazan · 2021 · UNIPA Springer series
65. Differential Diagnosis of Multiple Primary and Intra-lung Metastasis of Lung Cancer by Multiple Gene Detection
    Liuyang Xu, Jin Chen, Yupeng Zeng, Pan Ji, Shuaishuai Zhuo, Li Xiao, Zhihong Zhang · 2020
66. A pairwise radiomics algorithm - lesion pair relation estimation (PRE) model for distinguishing multiple primary lung cancer (MPLC) from intrapulmonary metastasis (IPM)
    Ting-Fei Chen, Lei Yang, Hai-Bin Chen, Hao‐Shuai Yang, Zhen-Tian Wu, Honghe Luo, Qiong Li, Ying Zhu · 2022 · Research Square
67. Liquid Biopsy for Early Diagnosis of Hepatocellular Carcinoma: Current State and Future Perspectives
    Huiqin Jiang, Wenjing Yang, Anli Jin, Hao Wang, Tong Li, Jingrong Xian, Wei Chen, Ling Ding, Beili Wang, Wei Guo · 2023 · Current Chinese Science
68. Genomic discordances and heterogeneous mutational burden, PD-L1 expression and immune infiltrates of non-small cell lung cancer metastasis
    Jianghua Wu, Luning Mao, Wanjun Lei, Wei Sun, Xin Yang, Yanhui Zhang, Xiaozheng Huang, Dongmei Lin · 2024 · Journal of Clinical Pathology
69. Genome Sequencing of Multiple Primary Lung Cancers Harbouring Mixed Histology and Spontaneously Regressing Small-Cell Lung Cancer
    Valentina Thomas, Ahmed Rashed, Clare M. Faul, Siobhan A. Nicholson, Vincent Young, John Hanson, Bryan T. Hennessy, Sinéad Toomey, Simon J. Furney · 2024 · Journal of Personalized Medicine
70. Additional file 2 of Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma
    Runzhe Chen, Jun Li, Junya Fujimoto, Lingzhi Hong, Xin Yang Hu, Kelly Quek, Ming Tang, Akash Mitra, Carmen Behrens, Chi-Wan B. Chow et al. · 2022 · Figshare
71. Multiple pulmonary ground-glass nodules: Challenges and advances
    Fei-Fei Guo, Jue Huang, Fei Chen, Jiuwei Cui · 2023 · journal of nutritional oncology
72. Additional file 1 of Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma
    Runzhe Chen, Jun Li, Fujimoto, Junya, Hong, Lingzhi, Hu, Xin, Kelly Quek, Ming Tang, Mitra, Akash, Carmen Behrens, Chow, Chi-Wan et al. · 2022 · Figshare
73. Additional file 1 of Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer
    Anne Marie McCarthy, Kumar, Nitya Pradeep, He, Wei, Susan Regan, Michaela Welch, Beverly Moy, Iafrate, A. John, Andrew Tan Chan, Aditya Bardia, Armstrong, Katrina · 2020 · Figshare
74. Molecular approaches to brain metastasis
    David Gritsch, Consuelo Torrini, Priscilla Kaliopi Brastianos · 2026 · Elsevier eBooks
75. Solitary Parotid Metastasis as an Atypical Site of Recurrence in Lung Squamous Cell Carcinoma: A Diagnostic Difficulty
    Mamadou Alpha Prateaux, Mohamed Amine Haouane, Issam Rharrassi, Mohamed Amine Azami · 2026 · Cureus
76. Molecular Testing in Pulmonary Tumors
    Jeffrey Tanguay, Shirin Karimi, David M. Hwang, Ming‐Sound Tsao · 2014 · Springer eBooks